• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Colchicine for Cardiovascular Prevention: Clarity Amidst the Confusion.

作者信息

Imazio Massimo

机构信息

Department of Medicine, University of Udine, 33100, Udine, Italy.

Cardiothoracic Department, University Hospital Santa Maria della Misericordia, ASUFC, Piazzale Santa Maria della Misericordia 15, 33100, Udine, Italy.

出版信息

Am J Cardiovasc Drugs. 2025 Sep 1. doi: 10.1007/s40256-025-00754-9.

DOI:10.1007/s40256-025-00754-9
PMID:40889094
Abstract
摘要

相似文献

1
Colchicine for Cardiovascular Prevention: Clarity Amidst the Confusion.用于心血管预防的秋水仙碱：混乱中的明晰
Am J Cardiovasc Drugs. 2025 Sep 1. doi: 10.1007/s40256-025-00754-9.
2
Colchicine for the primary prevention of cardiovascular events.秋水仙碱用于心血管事件的一级预防。
Cochrane Database Syst Rev. 2025 Feb 10;2(2):CD015003. doi: 10.1002/14651858.CD015003.pub2.
3
Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis.秋水仙碱用于血管事件二级预防的长期试验：一项荟萃分析。
Eur Heart J. 2025 Jul 7;46(26):2552-2563. doi: 10.1093/eurheartj/ehaf174.
4
Colchicine for prevention of major adverse cardiovascular events: a meta-analysis of randomized clinical trials.秋水仙碱预防主要不良心血管事件：一项随机临床试验的荟萃分析
J Cardiovasc Med (Hagerstown). 2025 Jul 1;26(7):359-368. doi: 10.2459/JCM.0000000000001744. Epub 2025 Jun 5.
5
Colchicine for secondary prevention of vascular events: a meta-analysis of trials.秋水仙碱用于血管事件的二级预防：试验的荟萃分析
Eur Heart J. 2025 Jul 7;46(26):2564-2575. doi: 10.1093/eurheartj/ehaf210.
6
Colchicine for cardiovascular medicine: a systematic review and meta-analysis.秋水仙碱在心血管医学中的应用：系统评价和荟萃分析。
Future Cardiol. 2022 Aug;18(8):647-659. doi: 10.2217/fca-2020-0206. Epub 2022 Jul 5.
7
Cardiovascular Benefit of Colchicine in Relation to Baseline Risk: A Secondary Analysis of the LoDoCo2 Trial.秋水仙碱与基线风险相关的心血管益处：LoDoCo2试验的二次分析
J Am Heart Assoc. 2025 May 20;14(10):e038687. doi: 10.1161/JAHA.124.038687. Epub 2025 May 15.
8
The efficacy of colchicine compared to placebo for preventing ischemic stroke among individuals with established atherosclerotic cardiovascular diseases: a systematic review and meta-analysis.秋水仙碱与安慰剂相比，对已确诊的动脉粥样硬化性心血管疾病患者预防缺血性卒中的疗效：一项系统评价和荟萃分析。
Scand Cardiovasc J. 2025 Dec;59(1):2441112. doi: 10.1080/14017431.2024.2441112. Epub 2024 Dec 21.
9
Colchicine for the Secondary Prevention of Cardiovascular Diseases: A Cumulative-Dose Meta-analysis of Randomized Controlled Trials including 31,397 Subjects Worldwide.秋水仙碱用于心血管疾病的二级预防：一项纳入全球31397名受试者的随机对照试验的累积剂量荟萃分析。
Am J Cardiovasc Drugs. 2025 Sep 1. doi: 10.1007/s40256-025-00743-y.
10
Colchicine for prevention of cardiovascular events.秋水仙碱用于预防心血管事件。
Cochrane Database Syst Rev. 2016 Jan 27;2016(1):CD011047. doi: 10.1002/14651858.CD011047.pub2.

本文引用的文献

1
Comparative Efficacy of Pharmacological Interventions for Heart Failure with Reduced Ejection Fraction Between Asian and White Patients: A Meta-analysis of Randomized Controlled Trials.亚洲和白人患者中射血分数降低的心力衰竭药物干预的比较疗效：一项随机对照试验的荟萃分析。
Am J Cardiovasc Drugs. 2025 Jul 11. doi: 10.1007/s40256-025-00745-w.
2
Colchicine for prevention of major adverse cardiovascular events: a meta-analysis of randomized clinical trials.秋水仙碱预防主要不良心血管事件：一项随机临床试验的荟萃分析
J Cardiovasc Med (Hagerstown). 2025 Jul 1;26(7):359-368. doi: 10.2459/JCM.0000000000001744. Epub 2025 Jun 5.
3
Colchicine for Secondary Prevention in Established ASCVD: A Systematic Review and Meta-Analysis.
Eur J Prev Cardiol. 2025 Jun 12. doi: 10.1093/eurjpc/zwaf332.
4
Colchicine in acute coronary syndromes: a systematic review and meta-analysis of randomised controlled trials.
Heart. 2025 May 16. doi: 10.1136/heartjnl-2025-325826.
5
The efficacy and safety of low dose colchicine in atherosclerotic cardiovascular disease - A systematic review and meta-analysis.
Eur J Prev Cardiol. 2025 May 16. doi: 10.1093/eurjpc/zwaf302.
6
Colchicine for secondary prevention of vascular events: a meta-analysis of trials.秋水仙碱用于血管事件的二级预防：试验的荟萃分析
Eur Heart J. 2025 Jul 7;46(26):2564-2575. doi: 10.1093/eurheartj/ehaf210.
7
Colchicine in acute coronary syndromes: the present and the possible future.秋水仙碱在急性冠状动脉综合征中的应用：现状与可能的未来。
Nat Rev Cardiol. 2025 Apr;22(4):215-216. doi: 10.1038/s41569-025-01124-3.
8
Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial.长期使用秋水仙碱预防非心源性卒中的血管复发性事件（CONVINCE）：一项随机对照试验。
Lancet. 2024 Jul 13;404(10448):125-133. doi: 10.1016/S0140-6736(24)00968-1. Epub 2024 Jun 7.
9
Colchicine in Patients with Chronic Coronary Disease.秋水仙碱治疗慢性冠心病
N Engl J Med. 2020 Nov 5;383(19):1838-1847. doi: 10.1056/NEJMoa2021372. Epub 2020 Aug 31.
10
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.心梗后小剂量秋水仙碱的疗效和安全性。
N Engl J Med. 2019 Dec 26;381(26):2497-2505. doi: 10.1056/NEJMoa1912388. Epub 2019 Nov 16.